Company: PACB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001299130-25-000156
Chunk: 84

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 84
---
4.32%Dividend yield ——Weighted average grant date fair value per share$0.90$1.43 The fair value of shares to be issued under the ESPP was estimated using the following assumptions:Six Months Ended June 30,20252024Expected term in years0.5 — 2.00.5 — 2.0Expected volatility 113%81%Risk-free interest rate 3.96% — 4.31%4.54% — 5.27%Dividend yield ——Weighted average grant date fair value per share$0.93$2.78

NOTE 8.  NET LOSS PER SHAREBasic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares of common stock outstanding and potential shares assuming the dilutive effect of the Notes, using the if-converted method, and outstanding equity awards using the treasury stock method.

Q2 Fiscal 2025 Form 10-Q24

The following table presents the calculation of the basic and diluted net loss per share amounts presented in the condensed consolidated statements of operations and comprehensive loss:Three Months Ended June 30,Six Months Ended June 30,(In thousands, except per share amounts)2025202420252024Numerator:Net loss$(41,930)$(173,319)$(468,005)$(251,497)Denominator:BasicWeighted average shares used in computingbasic net loss per share300,162272,385298,519270,982Basic net loss per share$(0.14)$(0.64)$(1.57)$(0.93)DilutedWeighted average shares used in computingdiluted net loss per share300,162272,385298,519270,982Diluted net loss per share$(0.14)$(0.64)$(1.57)$(0.93)The following shares issuable upon conversion of the Notes and outstanding equity awards were excluded from the computation of diluted net loss per share for the periods presented because the effect of including such shares would have been antidilutive:Three Months Ended June 30,Six Months Ended June 30,(In thousands)2025202420252024Shares issuable upon conversion of convertible senior notes61,41531,06361,41531,063Equity awards44,64333,37044,